# 바이오스페이스 일일 뉴스 리포트 - 2025년 12월 04일


## 주요 헤드라인

1. **New UK/EU Rules and AI Adoption Define CRO Priorities for 2026 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/new-uk-eu-rules-and-ai-adoption-define-cro-priorities-for-2026>

2. **New UK/EU Rules and AI Adoption Define CRO Priorities for 2026 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/new-uk-eu-rules-and-ai-adoption-define-cro-priorities-for-2026>

3. **Capricor Heads Back to FDA With Pivotal Results for DMD Cardiomyopathy Therapy (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/capricor-heads-back-to-fda-with-pivotal-results-for-dmd-cardiomyopathy-therapy>

4. **Capricor Heads Back to FDA With Pivotal Results for DMD Cardiomyopathy Therapy (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/capricor-heads-back-to-fda-with-pivotal-results-for-dmd-cardiomyopathy-therapy>

5. **BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/bms-delays-cobenfy-alzheimers-psychosis-data-after-irregularities-in-phase-iii-study>

6. **Harmony’s Dravet Drug Halves Monthly Seizures in Late-Stage Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/harmonys-dravet-drug-halves-monthly-seizures-in-late-stage-study>

7. **Prasad’s Leaked FDA Memo, Alzheimer’s Ups and Downs, Next-Gen Obesity Drugs (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/prasads-leaked-fda-memo-alzheimers-ups-and-downs-next-gen-obesity-drugs>


---
*2025년 12월 04일 바이오스페이스 뉴스 피드에서 생성된 리포트*